Ultragenyx Pharmaceutical (RARE)'s 30-day implied volatility (IV30) was 42.8% at the close on November 2, 2026, down from 63.3% the day before, against a 52-week range of 30.9% to 183.2%. Its 20-day historical volatility was 51.8%.
Data as of November 2, 2026.